Cargando…
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites
BACKGROUND: Human populations exposed to low malaria transmission present particular severe risks of malaria morbidity and mortality. In addition, in a context of low-level exposure to Anopheles vector, conventional entomological methods used for sampling Anopheles populations are insufficiently sen...
Autores principales: | Poinsignon, Anne, Cornelie, Sylvie, Ba, Fatou, Boulanger, Denis, Sow, Cheikh, Rossignol, Marie, Sokhna, Cheikh, Cisse, Badara, Simondon, François, Remoue, Franck |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733152/ https://www.ncbi.nlm.nih.gov/pubmed/19674487 http://dx.doi.org/10.1186/1475-2875-8-198 |
Ejemplares similares
-
Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites
por: Poinsignon, Anne, et al.
Publicado: (2008) -
gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas
por: Sagna, André Barembaye, et al.
Publicado: (2013) -
Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites
por: Drame, Papa M, et al.
Publicado: (2015) -
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal
por: Drame, Papa M, et al.
Publicado: (2012) -
Human Antibody Responses to the Anopheles Salivary gSG6-P1 Peptide: A Novel Tool for Evaluating the Efficacy of ITNs in Malaria Vector Control
por: Drame, Papa Makhtar, et al.
Publicado: (2010)